"10.1371_journal.pone.0037885","plos one","2012-06-08T00:00:00Z","Luc Dupuis; Reinhard Dengler; Michael T Heneka; Thomas Meyer; Stephan Zierz; Jan Kassubek; Wilhelm Fischer; Franziska Steiner; Eva Lindauer; Markus Otto; Jens Dreyhaupt; Torsten Grehl; Andreas Hermann; Andrea S Winkler; Ulrich Bogdahn; Reiner Benecke; Bertold Schrank; Carsten Wessig; Julian Grosskreutz; Albert C Ludolph; the GERP ALS Study Group","Department of Neurology, University of Ulm, Ulm, Germany; U692 - Laboratoire de Signalisations Moléculaires et Neurodégénérescence, INSERM, Strasbourg, France; UMRS692, Faculté de Médecine, Université de Strasbourg, Strasbourg, France; Department of Neurology, Hannover Medical School, Hannover, Germany; Department of Neurology, University of Bonn, Bonn, Germany; Department of Neurology, Charité University Hospital, Berlin, Germany; Department of Neurology, University of Halle-Wittenberg, Halle, Germany; Institute of Epidemiology and Medical Biometry, University of Ulm, Ulm, Germany; Department of Neurology, Ruhr-Universität, Bochum, Germany; Department of Neurology, Dresden University of Technology, Dresden, Germany; Department of Neurology, Technical University, Munich, Germany; Department of Neurology, University of Regensburg, Regensburg, Germany; Neurology clinic, University of Rostock, Rostock, Germany; Deutsche Klinik für Diagnostik, Wiesbaden, Germany; Department of Neurology, University of Würzburg, Würzburg, Germany; Department of Neurology, University Hospital, Jena, Germany","Conceived and designed the experiments: RD MTH TM SZ WF ACL. Performed the experiments: RD MTH TM SZ JK WF FS EL MO TG AH ASW UB RB BS CW JG ACL. Analyzed the data: LD JK MO JD ACL. Wrote the paper: LD.","Takeda Pharma GmbH partly funded this study. The trial used Pioglitazone which is a Takeda product. There are no other patents, products in development or marketed products to disclose. This does not alter the authors’ adherence to all the PLOS ONE policies on sharing data and materials.","2012","06","Luc Dupuis","LD",21,TRUE,6,18,5,1,TRUE,TRUE,FALSE,0,NA,FALSE
